Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The BCG vaccine has been found to be more effective against the most common form of tuberculosis than previously thought, according to a new study in Clinical Infectious Diseases.
Bacillus Calmette Guérin (BCG) vaccine is included in the childhood vaccination programme of many countries, and is the only licensed vaccine against tuberculosis (TB). However, it has previously been thought to only be effective against the less common forms of the disease that occur away from the lungs. Its efficacy against pulmonary TB, found in the lungs and by far the greatest burden of TB, has varied widely depending on location, ranging from 0% in South India to 80% in the UK.
In order to better understand the reason behind this variability, researchers led by the London School of Hygiene & Tropical Medicine conducted a systematic review of global literature on all reported BCG trials across 10 medical electronic databases, looking at the factors affecting its level of protection against pulmonary TB.
The research shows for the first time that the BCG vaccine is actually highly protective against pulmonary TB in all parts of the world, including significant protection when administered in the tropics.
The main reason for the apparent variation in protection against disease seen in previous studies was found to be due to prior infection reducing the efficacy of the vaccine. BCG vaccination for those with no history of prior TB infection, including young infants, showed a much higher efficacy against pulmonary TB.
The study therefore highlights a new role for BCG in fighting pulmonary TB, a need for early vaccination, and further suggests that any new TB vaccine based on BCG will also need to be administered before infection has occurred.
Lead author Dr Punam Mangtani, Clinical Senior Lecturer in Epidemiology at the London School of Hygiene & Tropical Medicine, said: "This research corrects a longstanding misconception that BCG is ineffective against pulmonary disease, and confirms its importance in controlling the major burden from TB and main source of transmission in all settings. Now that we know previous infection can lower the protection provided by the vaccine, it is important that BCG is given as early as possible in a person's life, and ideally immediately after birth."
The research was funded by the UK National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre.
Punam Mangtani, Ibrahim Abubakar, Cono Ariti, Rebecca Beynon, Laura Pimpin, Paul E M Fine, Laura C Rodrigues, Peter G Smith, Marc Lipman, Penny F Whiting, Jonathan A. Sterne. Protection by BCG against tuberculosis: a systematic review of randomised controlled trials. Clinical Infectious Diseases. DOI: 10.1093/cid/cit790
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Immune System / Vaccines category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
London School of Hygiene & Tropical Medicine. "BCG vaccine more effective than previously thought." Medical News Today. MediLexicon, Intl., 27 Dec. 2013. Web.
7 Mar. 2014. <http://www.medicalnewstoday.com/releases/270541>
London School of Hygiene & Tropical Medicine. (2013, December 27). "BCG vaccine more effective than previously thought." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270541.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.